Maddocks Shares Updates on Emerging Treatment Strategies in MCL
OncLive,
Kami Maddocks, MD Efforts to widen the treatment armamentarium for patients with mantle cell lymphoma (MCL) have been thwarted…
Andre H. Goy, MD, on Unresolved Questions in Mantle Cell Lymphoma
Cancer Network,
“It’s time to dissect MCL and account for its molecular heterogeneity when refining our treatment.” Andre H.
Promising Efficacy and Safety Profile Seen With Concurrent Ibrutinib and Venetoclax for R/R Mantle Cell Lymphoma
Cancer Network,
Phase 3 data suggest that concurrent treatment with ibrutinib and venetoclax yielded promising efficacy for patients with…